World-class molecular imaging infrastructure.
MIBIOTRACE provides access to an integrated preclinical imaging ecosystem, combining radiochemistry, multimodal imaging and quantitative analysis within a single workflow.
Overview
MIBIOTRACE operates a fully integrated preclinical molecular imaging platform, bringing together an animal facility, radiopharmacy laboratory, multimodal preclinical imaging suite and advanced image analysis unit under one roof. From study design and labeling to imaging, quantitative analysis and reporting, the entire workflow is performed on-site, ensuring efficient execution, high reproducibility and consistently high-quality preclinical studies.
Fully integrated infrastructure
Radiopharmacy Laboratory
On-site labeling and radiotracer quality control.
Animal Facility
Specialized animal housing with access to a wide range of disease models, fully integrated with the preclinical imaging platform.
Multimodal Preclinical Imaging Suite
PET/MRI, PET/CT, SPECT/CT and CT scans for whole-body, longitudinal, in vivo quantitative molecular imaging.
Quantitative Imaging Analysis
TheraPET4D® provides robust quantitative data beyond conventional image analysis, improving sensitivity and reproducibility.
Ready to start your molecular PET imaging study?
Schedule a technical consultation with the MIBIOTRACE team.